Project Details
Description
A Phase 1/2 Dose Escalation Study of the BCL-2 Inhibitor ZN-d5 and the WEE1 Inhibitor ZN-c3 in Subjects with Acute Myeloid Leukemia
| Status | Active |
|---|---|
| Effective start/end date | 10/7/22 → 10/7/27 |
Funding
- K-GROUP ALPHA, INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.